The synthesis of modified bimodal mesoporous materials (BMMs) with a small pore size of around 2.9 nm and a large pore size of about 20 nm has been performed via post-grafting methods. To study the application of functionalized BMMs in drug delivery, loading and releasing profiles using aspirin as model drug were carried out. XRD, SEM, TEM, N 2 adsorption, FT-IR, 29 Si-NMR, TG and UV-Vis spectroscopy were used to characterize the related samples. The post-grafting modification was performed through the weak chemical interaction or hydrogen bonding in between OH groups of the mesopore surface and 3-aminopropyltriethoxysilane (N-TES) or 3-(2-aminoethylamino) propyltrimethoxysilane (NN-TES). The results showed that N-TES groups with different amount and NN-TES groups were successfully incorporated onto the mesopore surface. Subsequently, the controlled aspirin delivery properties from the resulting modified BMMs were investigated in detail. The aspirin adsorption experiments indicated that the adsorption capacities of modified BMMs were improved with the increasing amount of N-TES groups, while the NN-TES functionalized samples showed higher adsorption capacity than N-TES modified samples with the same ratio of modification. The most reason is that the interaction between the NN-TES groups and aspirin molecules is stronger than that between the N-TES groups and aspirin molecules. The in vitro tests exhibited that aspirin release behaviors mainly depended on the variation of the amount and species of the functional groups in mesoporous carries. According to the Korsmeyer-Peppas model, it is found that the kinetic release constant k reduced with the increase amount of the amino groups on the mesopore surface of modified BMMs, suggesting that the aspirin release rate from the pores of BMMs was influenced directly by organic groups on the surface. The release exponent n of all the situations were above 0.5, indicating the drug release mechanism followed a non-Fickian model that was diffusion based. Therefore, this type of materials described in this paper is of strong potential for the controlled drug release applications.
INTRODUCTION
During the past decades, several research groups have reported the design of drug sustained/controlled delivery systems based on the mesoporous silicas. Initially, the main efforts have been focused on the development of the loading of drugs into mesoporous silica-based particles and the subsequent release behaviors. Vallet-Regi and co-workers demonstrated the sustained-release property of the modified mesoporous silica materials (such as MCM41and SBA-15) for drugs. [1] [2] [3] It has been found that the release kinetics of drugs from the mesoporous silica-based * Author to whom correspondence should be addressed.
carriers depend on several material characteristics including pore size, 4 5 pore connectivity 5 and the chemical composition of the silica surface. 3 6 Also, the loading amount of the desirable drug is affected by conditions under which the adsorption measurement is carried out, including pH value, solvent and initial drug concentration. 7 8 All results have clearly shown that the suitable texture properties and structure parameters make mesoporous silica materials with one-dimensional mesoporous channel promising supports for the hosting and further release of a large variety of drug molecules with therapeutic activity.
However, there is no further investigation of the influences of the controlled hierarchical mesoporous structure from micro-to meso scale of the above carriers on the Delivered by Ingenta to: Dental Library Seoul Natl Univ IP : 133.11.175.143 Fri, 13 Apr 2012 02:14:09
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Bimodal Mesoporous Silicas Functionalized with Different Level and Species of the Amino Groups storage capacity and the release rate. The related loading and release mechanism which underlies the adsorption or diffusion of the loaded drug molecules in the confined delivery system has not been essentially probed.
Recently, several studies [9] [10] [11] pointed out that mesoporous carriers having interconnecting three-dimensional pore networks can not only increase the storage capacity of drug molecules, but also can provide delivery pathways for drug molecules diffusion, obviously implying that the controlled three-dimensional pore structure in mesoporous matrix is an important strategy and feasible pathway to obtain the desired drug delivery profile. 7 12 To the best of our knowledge, the three-dimensional mesoporous silicas used as controlled release carrier have not been well explored yet. Izquierdo-Barba reported that MCM-48 with cubic ordered structure has been applied to the encapsulation of small molecule drugs. 10 Recently, Heikkila et al. revealed that TUD-1 with the foam-like mesopores has high accessibility for potential substrates of biological interest which was ascribed to the presence of a hierarchical threedimensional mesopore system.
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In this paper, we report the application of a novel bimodal mesoporous silicas (denoted as BMMs) 13 as a drug delivery carrier. BMMs materials consist of welldefined small mesopores of 3 nm as well as large interparticles pores. Whereas, the surface area typically lies in the 700-1000 m 2 /g range, and the pore volume varies from 0.8 up to 1.5 cm 3 /g. Therefore, compared with the traditional mesoporous material, the novel bimodal pore systems of BMMs material allow the larger drug molecules easier accessibility to the active site due to disappearance of diffused limitation, and thereby improve the desired drug loading/release efficiencies and minimize the blocking influence of mesoporous channels.
14 All these features of BMMs could provide an ideal medium for drug storage and controlled release.
Aspirin is an extensively employed analgesic and antiinflammatory drug, containing one carboxylic acid group, which can form stronger chemical bonding with many functional groups via acid-base reaction. 15 It is also a wellcharacterized drug, which could be easily monitored by the absorbance bands at 273 nm by UV-Vis spectroscopy. We chose aspirin as model drug herein also because of its good pharmacological activity, which ensures its easy diffusion into or out of the bimodal mesoporous channels. In this work, controlled drug delivery carriers can be fabricated by a simple and effective approach through local surface modification in a novel controlled bimodal mesoporous silica with 3-aminopropyltriethoxysilane (N-TES) at different levels and 3-(2-aminoethylamino)propyltrimethoxysilane (NN-TES). The samples were well characterized by means of XRD, Fourier transform-infrared spectroscopy (FT-IR), Scanning electron microscopy (SEM), Transmission electron microscopy (TEM), 29 Si MAS NMR, N 2 adsorption, Thermogravimetric analyses (TGA) and UV-VIS spectra.
In addition, the aspirin loading and releasing in vitro study with the simulated body fluid (SBF) on this system based on their bimodal mesoporous properties were extensively investigated.
EXPERIMENTAL DETAILS
Chemicals
The chemicals used in this study include cetyltrimthylammonium bromide (CTAB, A. R.), ethyl silicate (TEOS, A. R.), ammonium hydroxide (A. R.), sodium chloride (A. R.), sodium hydrogen carbonate (A. R.), potassium chloride (A. R.), potassium phosphate dibasic (A. R.), magnesium chloride hexahydrate (A. R.), calcium chloride anhydrous (A. R.), sodium sulfate anhydrous (A. R.), tris(hydroxymethyl)aminomethane (A. R.) and hydrochloric acid (A. R.). They were obtained from Sinopharm Chemical Reagent Co., Ltd. Besides, 3-aminopropyltriethoxysilane (N-TES, 97%), 3-(2-aminoethylamino) propyltrimethoxysilane (NN-TES, 96%) and 0-Acetylsalicylic acid (Aspirin, 99%) were supplied by Alfa Aesar.
Experimental Procedure
Preparation of BMMs
BMMs material was synthesized partially based on the literature method. 13 In a typical process, CTAB (2.6115 g) was dissolved completely in water (104 ml) to get a transparent solution. TEOS was added to the solution while stirring. Finally, ammonium hydroxide was added quickly to adjust pH to around 9. The mixture was stirred continuously to get a white gel. The resultant precipitates were filtered, washed, and dried at 120 C for 3 h. To remove surfactant, the solid was calcined at 550 C for 6 h, with a heating rate of 5 C/min from room temperature to 550 C.
Modification of BMMs
The post-synthesis modification method was employed in this study. Prior to the experiment, the BMMs was dried at 150 C under vacuum for 5 h. BMMs (1.0 g) was added to chloroform solution (100 mL) of N-TES (0.02 mol/L, 0.06 mol/L, 0.1 mol/L, respectively) and NN-TES (0.06 mol/L) and stirred for 5 h. The functionalized BMMs were filtered, washed with ethanol, dried at 80 C for 3 h and finally marked as 0.02N-BMMs, 0.06N-BMMs, 0.1N-BMMs and 0.06NN-BMMs, respectively.
Aspirin Loading and Release
The drug loading process was carried out by the immersion of functionalized BMMs (0.02 g) in aspirin ethanol solution with a certain concentration (1 mg/ml). The weight ratio of carrier:drug was 4:1. The aspirin adsorbed on the exterior surfaces of the carrier was removed by washing the sample with ethanol. Finally, the sample was dried at 50 C for 3 h. A UV-vis spectrophometer was used to monitor the adsorbed amount of aspirin with the signal at 273 nm. The amount of adsorbed drug was calculated by the mass balance before and after adsorption. 3 Dissolution experiments were performed in SBF. The SBF has a composition and ionic concentration similar to that of human plasma (pmm:
of 142.0/ 5.0/2.5/1.5/147.8/4.2/1.0/0.5). 16 The drug loaded BMMs sample (0.1 g) was soaked in SBF (50 ml) at 37 C. The drug concentration was detected using a UV-vis spectrophometer. The cumulative release amount was determined by the mass balance equation similar to the previous section. 3 
Characterization Methods
Powder XRD data were collected on a Bruker-AXS D8 Advance X-ray diffactometer using Cu K radiation ( K = 0 154056 nm) source of wavelength 1.5406 Å at 35 kV and 20 mA and 2 ranging from 0.6 to 10.0 with a scan speed of 2.0 /min. SEM micrographs were recorded on a Hitachi-S4700 microscope. TEM was performed on a Tecnai F20 at 200 kV. FT-IR spectra were observed on TENSOR27 BRUKER. N 2 adsorption and desorption isotherms at −196 C were obtained using a Micromeritics ASAP 2000 system. The sample was pretreated at 100 C overnight in vacuum. The isotherm data were analyzed by BET (Brunauer-Emmett-Teller) and the plots of the corresponding pore size distribution were obtained from the desorption branches of the isotherms by using BJH (Barrett-Joyner-Halenda) model. TGA were carried out between 25 and 800 C using a Seiko TG/DTA 320 with an N 2 flow rate 100 mL/min and a heating rate of 10 C/min. UV-vis spectra were recorded on a SHIMADZU UV-2450 spectrophotometer. The solid-state 29 Si MAS NMR spectra were acquired on a Bruker AV300 spectrometer using 5 mm probe under magic-angle spinning. The elemental compositions of the samples were analyzed by varioEL superuser.
RESULTS AND DISCUSSION
Characterization of Mesoporous BMMs
Figure 1(A) represents the XRD patterns for functionalized BMMs with different -NH 2 content. As can be seen, the XRD pattern of BMMs ( Fig. 1(A-a) ) clearly exhibits two diffraction peaks in the 2 range 2 -10 , indexed as (100) and (110) respectively, which indicated the existence of the mesopores. 13 However, the (110) peak is not obvious; the possible reason is that the peak (100) is too broad with high intensity in the XRD pattern. After introduction treatment of -NH 2 groups (0.02 mol/L, 0.06 mol/L and 0.1 mol/L, respectively) onto the pore surface of the BMMs (Fig. 1(A-b, c, and d) ), the (100) peak intensity gradually decreases. On the other hand, as the amount of the functional group increases, the (100) peak position of 2 shifts from 1.84 ( Fig. 1(A-a) ) to 1.88 ( Fig. 1(A-b) ), 1.90 ( Fig. 1(A-c) ) and 2.02 ( Fig. 1(A-d) ), respectively, and the corresponding d space value decreases from 4.80 nm to 4.70 nm, 4.65 nm and 4.37 nm. These observations indicate that the mesoporous structure somewhat disordered, and therefore suggest that the introduction of functional groups onto the BMMs mesostructure has remarkable disruptive affection due to the condensation between siloxane and functional group during the process. 17 18 Meantime, the XRD patterns of BMMs functionalized with different kinds of groups with the same amount are depicted in Figure 1(B) . Besides the disruptive affection, after modification with -NH-CH 2 -CH 2 -NH 2 group (whose size is bigger than that of -NH 2 group), the d space value of 0.06NN-BMMs decreases from 4.80 nm of BMMs (Fig. 1(B-a) ) to 4.50 nm (Fig. 1(B-e) ), much smaller than 4.65 nm (Fig. 1(B-c) Fig. 2(A) ) for BMMs exhibits abundant mesopores with a rounded particle of around 50 nm. TEM image (Fig. 2(B) ) confirms the presence of a bimodal mesoporous system, which shows uniform internanoparticle mesopores with a diameter of around 25 nm and a large number of narrow small pores with a size of 3 nm.
The porosity of the BMMs and 0.06NN-BMMs were characterized by using the surface area, the total pore volume and pore size distribution from the N 2 adsorptiondesorption isotherms. As can be seen in Figure 3 , the isotherms of BMMs exhibit two inflections: the first occurs at relative pressure 0 3 < P/P 0 < 0 5 and the second, much steeper one, at 0 75 < P/P 0 < 1 (Fig. 3(a) ). While, for 0.06NN-BMMs (Fig. 3(B-c) ), the first condensation becomes weak and the second one changes slightly. The corresponding pore size distribution in Figure 3 (insert) reveals two pore sizes. Both of them possess a bimodal pore size distribution with the narrow small pore distribution around 2.6 nm and the large pores around 24 nm. BMMs ( Fig. 3(a) ) exhibits BET surface value and pore volume of 1122 m 2 /g and 1.7 cm 3 /g, respectively. The isotherms of 0.06NN-BMMs (Fig. 3(b) ) reveal a lower N 2 (A) (B) uptake, resulting in a decreased BET surface value and pore volume of 705 m 2 /g and 0.9 cm 3 /g, respectively, suggesting the presence of amino-organic moieties distributed inside the mesopore channels. 17 This conclusion is also supported by the decrease of the small pore size, from 2.7 nm for BMMs to 2.2 nm for 0.06NN-BMMs.
The 29 Si MAS NMR spectra of the samples before and after modification with N-TES and NN-TES were displayed in SI. The chemical shifts of BMMs and its relative intensities of three resonances at −111, −101, and −92 ppm are assigned to the silicon sites of Q 4 , Q 3 , and Q 2 , respectively. 19 For the samples after modification with N-TES and NN-TES (See SI), additional resonances of T 2 and T 3 appear at around −60 ppm and −65 ppm, which are attributed to the reaction of N-TES/NN-TES with -OH groups of mesoporous surface, resulting in the formation of surface ligands attached to the framework of BMMs. 20 This observation could further confirm the successful grafting of the -NH 2 /-NH 2 -CH 2 -CH 2 -NH 2 group onto the mesopores surface of BMMs.
The results of elemental analysis (Table I) (0.02N-BMMs, 0.06N-BMMs and 0.1N-BMMs) increased from 0 before modification to 1.805, 2.036 and 2.076 respectively with the addition of the N-TES. Meanwhile, the C content also increased and the C/N molar ratio of the three modified samples were around 3.7, almost consistent with that of 3-aminopropyl groups (-CH 2 -CH 2 -CH 2 -NH 2 (the C/N molar ratio is 3). Comparatively, the N content of sample 0.06NN-BMMs was 5.080, which was obviously higher than those of other three samples (0.02N-BMMs, 0.06N-BMMs and 0.1N-BMMs). This is due to the bigger modification groups 3-(2-aminoethylamino) propyl (-CH 2 -CH 2 -NH-CH 2 -CH 2 -NH 2 . Besides, after Aspirin (C 9 H 8 O 4 adsorption, the C/N molar ratio increased obviously ( for 0.06NN-BMMs can be assigned to the asymmetrical stretching of C-N, respectively, originating from the -Si-O-C n -NH 2 group of N-TES and NN-TES after the modification, 21 22 and verified the successful fuctionalization. For the A/0.06N-BMMs and A/0.06NN-BMMs, the peaks ascribed to the skeletal vibration of phenyl confirm that aspirin was successfully loaded into the pore channels of the modified BMMs.
Combined with the above XRD analysis, N 2 adsorptiondesorption isotherms, 29 Si MAS NMR and TG analysis (See SI), these observations further indicate the successful loading of the aspirin molecules inside the amine modified BMMs mesopores.
Adsorption of Aspirin
The curves of aspirin adsorption amount (per 200 mg carrier) as a function of time are depicted in Figure 4 . The results show that the loading kinetics of the aspirin in -NH 2 /-NH-CH 2 -CH 2 -NH 2 functionalized BMMs are very similar. The loading of aspirin in all samples become stable after 2 h, while the maximum loading amount varies. For the same functional group, the amount of aspirin loaded increases with the increasing amount of -NH 2 groups. For example, the loading amount of aspirin in 0.1N-BMMs (Fig. 4(b) ), 0.06N-BMMs (Fig. 4(c) ) and 0.02N-BMMs (Fig. 4(d) ) are 23.7 mg, 20.5 mg and 10.1 mg, respectively. For different amino groups, 0.06NN-BMMs sample has the best capability of aspirin adsorption with the amount of around 26.6 mg and the uptake is about 54% (50 mg Aspirin were used) by weight. The uptake amount is higher than that of an analogous drug, ibuprofen in MCM-48 (29%), LP-Ia3d (20%) 9 and TUD-1 (21%) with previous reports. 11 This may be partially attributed to the differences in the type of the functional groups and possible degree of interaction between the functional groups and aspirin molecules, the detailed investigation is being done in our group presently. Recently, Wang et al. 17 have made extensive studies, which indicated that mercaptopropyl and vinyl functionalized mesoporous materials showed high adsorption capacity for rhodamine 6G, while amine functionalized samples exhibited higher adsorption capacity for ibuprofen. Their results suggested that the type of functional groups introduced into the mesoporous materials have an important effect for their adsorption capacity.
Since aspirin contains a carboxylic acid group, which could interact favorably with the -NH 2 groups in the amino-functionalized samples via weak chemical bonding or hydrogen bonding, and therefore produce higher adsorption capacity of 0.06NN-BMMs sample than that of 0.06N-BMMs sample.
From the TG analysis (See SI), it was also observed that the stability of 0.06NN-BMMs loading samples has been improved upon encapsulation inside the channel of mesoporous silica. TG results indicated that the weight loss of 0.06N-BMMs loaded with aspirin took place at a certain temperature of ca. 571 C (Figure is not shown here) , while the mass loss of 0.06NN-BMMs loaded with aspirin took place at ca. 592 C (See SI). These results, on one hand, suggest that the increased of mass loss temperature was attributed to the strong chemical/physical adsorption force of the encapsulation of the drug, on the other hand, further indicate that the type and the amount of functional groups inside the channel of the mesopore systems are mainly responsible for the differences adsorption capacity of drug, which is consistent with those reported by others for similar functional groups. 23 Meanwhile, with a well-defined small mesopores of 3 nm and large mesopores of 24 nm, the novel bimodal mesopores of BMMs have less hindered diffusion and therefore allow the aspirin molecules to easier access to the mesopore channels with comparison of uniform mesopores, 11 for example MCM-41, TUD-1, and form stable adsorption between the organic groups and the drug molecules. 24 25 Obviously, it suggests that the hierarchical mesoporous structure with functionalized wall might greatly influence the loading profiles. The detailed mechanism will be discussed in the following work.
Drug Release
Previous studies have shown that the release of drugs from different mesoporous silica materials has been found to be mainly diffusion controlled with relation of BET surface areas, pore size and surface properties of mesoporous silica. 5 19 20 26-28 In the present study, the in vitro dissolution experiments were performed with the same parameters such as the pore architecture of BMMs as well as the properties of the dissolution medium, and hence, the unique influence of releases kinetics is the difference of the superficial organic group of BMMs. In order to compare the drug release characteristics of different functionalized BMMs, the dissolution data was fitted with the Korsmeyer-Peppas equation 29 f t = kt n , where f t is the fractional release of drug, k is the kinetic release constant incorporating structural and geometrical characteristics of the dosage form, t is the elapsed time and n is the release exponent indicating the drug release mechanism, concluding for values for a slab, of n = 0 5 for Fick diffusion and higher values of n, between 0.5 and 1.0, or n = 1 0, for mass transfer following a non-Fickian model. The model was found to describe the initial 60% aspirin release very well with high correlation coefficients (R 2 > 0 99) in all cases.
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The drug release profiles of aspirin/N-TES modified BMMs system are presented in Figure 5 . Due to the different amount of -NH 2 groups on the surface, the release kinetic behavior was different. The release process of 0.02/0.06/0.1N-BMMs drug carriers finished before 60 min and the kinetic release constant k were 10.1, 7.2 and 6.1 (correlation coefficient R > 0 99) respectively, while the exponent n were almost the same around 0.65 (R > 0 99). This fact may be explained by the existence of electrostatic interactions (-NH 3+ -O − bonding) between the amino groups at the bimodal mesopore surface of the BMMs material and the carboxylic groups from aspirin molecules, besides that there is also hydrogen bonding between the aspirin molecules and the silanol groups on the surface. In the initial stage (60% (wt), in Fig. 5 ), the weaker interactions (hydrogen bonding) should contribute to a more extensive release of the aspirin, and therefore the fast release rate is attributed to physically adsorbed and chemically adsorbed aspirin which located on and near the outside surface of the amino-modified BMMs sample. After that, the aspirin delivery profiles show a slow release, meaning that nearly 10% (wt) of the adsorbed aspirin remains entrapped inside the mesopores, which could be apparently ascribed to the electrostatic interactions for the aspirin diffusion from the bimodal mesopores system. With the increase of the amount of functional group, the amount of COO − -N + bonding increase and lead to a lower release rates. Similar observations have already been described previously by some reports, 1 24 28 30 while studying uniform mesoporous silicas loaded with ibuprofen and famotidine.
Meanwhile, compared with mesoporous MCM-41 carrier with pore size around 2.9 nm, (similar to small pore size of BMMs), and a unidirectional mesopore channels (k = 4 7, n = 0 71), as reported in a study concerning ibuprofen delivery, 23 the clearly much faster release of aspirin (k = 10 1) and more diffusion based (n = 0 65) of 0.02N-BMMs carrier demonstrated the unrestricted diffusion of the drug due to the high accessibility and the well-masssed transportation of the bimodal mesoporous network, which is accordance with the former research. 10 23 Therefore, it could be concluded that the hierarchical pores play an important role on drug delivery profiles, implying very beneficial method to improving drug releasing rate of poorly water-soluble drug with comparison of one-dimensional mesopores in the pharmaceutical application.
Interestingly, besides the amount of amino group on the bimodal mesoporous surface, the type of the amino functionalized group affects strongly the aspirin release rate. In order to investigate the effect of different organic groups on the release character, Figure 6 shows drug release profiles from Aspirin/0.06N-BMMs system and Aspirin/0.06NN-BMMs system in SBF medium. The amount of dissolved aspirin in SBF at typical sampling times of 10, 20, 40, and 60 min accumulated to 30%, 50%, 80% and 87% for 0.06N-BMMs, correspondingly, the amounts were 13%, 20%, 35% and 50% for 0.06NN-BMMs. The total time of aspirin released completely was 60 min for 0.06N-BMMs, whereas 150 min for 0.06NN-BMMs. The aspirin released faster from 0.06N-BMMs (kinetic release constant k = 7 2) than from 0.06NN-BMMs (k = 2 4). It was due to the stronger interaction force between aspirin and -NH-CH 2 -CH 2 -NH 2 group compared with that of Aspirin/0.06N-BMMs system, which slowed the expulsion of aspirin. Obviously, -NH-CH 2 -CH 2 -NH 2 group has the enhanced chemical interaction with aspirin, which leads to a slower rate of aspirin release from 0.06NN-BMMs carrier compared to 0.06N-BMMs carrier.
Therefore, these observation again show that the different functional groups played an important role for drug release kinetics by changing the amounts and type of functional groups, which was consistent with previous reports, 17 31 and in good agreement with the data obtained from the FT-IR spectra and TG analysis.
Meantime, exponent n was 0.65 for 0.06N-BMMs carrier and 0.74 for 0.06NN-BMMs carrier, indicating that the aspirin release mechanism of both systems followed a nonFickian model that was diffusion based. 29 It was deduced to the same pore architecture of materials, that the large pore channel might be favor of reducing steric diffusion resistance, and therefore the drug release from a big pore (besides 2.9 nm) of BMMs was more freely. We do not know its underlying mechanism, so a deeper study on the kinetics release is planned in future work.
CONCLUSION
In this study, two kinds of amino functionalized BMMs materials with varied grafting amount have been successfully prepared and their applications for drug delivery and release, typically for aspirin have been fully studied. The XRD and TEM results confirm the structural integrity of the bimodal mesopore architecture after the introduction treatment of functionalized groups, however, the mesoporous structure somewhat disordered. FT-IR and 29 Si NMR results provide the evidence that the -NH 2 groups and -NH-CH 2 -CH 2 -NH 2 groups have been successfully grafted in the BMMs.
By carefully modification of BMMs with -NH 2 organic groups, loading and releasing experiment results indicate that the bimodal mesopores structure in BMMs is suitable for aspirin inclusion. Using the same organic group -NH 2 with different modification level, the adsorbed capacities of aspirin was increased with the increment of the amount of the functional group, while the release rate slowed. Using various groups (-NH 2 and -NH-CH 2 -CH 2 -NH 2 with the same modification level, the former has drug loading amount of 12.1 mg and the latter of 26 The kinetic study suggests that, not only the electrostatic interactions between the amino groups at the bimodal mesopore surface of the BMMs and the carboxylic groups from aspirin molecules, but also hydrogen bonding between the aspirin molecules and the silanol groups on the surface of the BMMs control the adsorption and diffusion of drug molecules.
In conclusion, by varying the functional groups and grafting amount, BMMs has potential application on controlled drug loading and release. More importantly, it provides a promising carrier for controlled release of poorly water-soluble drug in the future pharmaceutical application.
